Breast Cancer Update

by Dr Neil Love
33

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

More
Recent Episodes
  • HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 21, 2025 – 01:39:35
  • HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 13, 2025 – 01:59:29
  • Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
    Apr 8, 2025 – 54:56
  • Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
    Mar 28, 2025 – 49:28
  • HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy
    Mar 28, 2025 – 01:03:10
  • 5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Mar 22, 2025 – 16:10
  • Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management
    Mar 12, 2025 – 59:43
  • 5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Mar 4, 2025 – 18:31
  • HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies
    Feb 15, 2025 – 02:02:17
  • 5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Feb 10, 2025 – 10:06
  • 5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Jan 31, 2025 – 11:58
  • Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients
    Jan 24, 2025 – 01:00:17
  • Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer
    Jan 17, 2025 – 01:00:59
  • Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3
    Jan 10, 2025 – 02:01:00
  • The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2
    Jan 3, 2025 – 02:00:37
  • HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1
    Dec 23, 2024 – 01:31:29
  • 5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Dec 16, 2024 – 11:59
  • Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
    Dec 5, 2024 – 59:42
  • 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    Nov 26, 2024 – 10:56
  • Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
    Nov 19, 2024 – 56:49
  • Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Breast Cancer
    Nov 15, 2024 – 01:03:53
  • Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
    Nov 1, 2024 – 59:29
  • Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
    Oct 25, 2024 – 45:46
  • Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
    Oct 18, 2024 – 59:22
  • Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
    Sep 25, 2024 – 49:55
  • Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
    Sep 6, 2024 – 01:02:34
  • Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    Aug 29, 2024 – 01:15:59
  • Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
    Aug 23, 2024 – 46:13
  • Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
    Aug 16, 2024 – 54:18
  • Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
    Aug 7, 2024 – 01:15:00
  • Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
    Jul 31, 2024 – 23:49
  • What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
    Jul 11, 2024 – 01:03:58
  • Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
    Jun 13, 2024 – 02:35:49
  • Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
    May 21, 2024 – 01:16:31
  • Virtual Case Library: Metastatic Triple-Negative Breast Cancer
    May 9, 2024 – 02:13:01
  • Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
    Mar 26, 2024 – 01:19:56
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
    Mar 15, 2024 – 01:05:47
  • Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
    Mar 11, 2024 – 37:38
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
    Feb 1, 2024 – 01:04:53
  • Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
    Nov 30, 2023 – 01:03:09
  • Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
    Sep 29, 2023 – 01:04:49
  • Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
    Aug 30, 2023 – 01:01:53
  • Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
    Aug 24, 2023 – 01:01:15
  • Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
    Aug 9, 2023 – 01:25:35
  • Oncology Today with Dr Neil Love: Special Edition — Current and Future Management of Breast Cancer
    Jul 21, 2023 – 58:52
  • Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
    Jun 16, 2023 – 01:01:32
  • Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3 of a 3-Part Series
    Apr 27, 2023 – 01:00:29
  • Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 2 of a 3-Part Series
    Mar 31, 2023 – 01:00:31
  • Recent Advances and Future Directions in Breast Cancer — With Dr Harold Burstein and Dr Virginia Kaklamani (Proceedings from a Symposium in Partnership with NCOA and SCOS)
    Mar 17, 2023 – 59:04
  • Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
    Mar 10, 2023 – 01:02:32
Recent Reviews
  • worldhobo
    Misc
    Overall wonderful updates. Listen to these while driving. Would however appreciate if the Oncology nursing series was on a separate platform or podcasts. When one is driving the podcasts roll on and I don’t want to hear the nursing discussions .It is somewhat dangerous to be messing with the podcasts while driving. (With all due respect to nursing collegues). Also in areas where there is no reception, manually skipping a talk often just causes the connection to drop.
  • hem/onc fellow
    Hem/onc fellow
    I’m very grateful for these podcasts and educational videos and definitely owe majority of my hem/onc knowledge to Dr. Love! Looking forward to many more episodes across different disease sites!
  • kdarbin
    Hemonc fellow
    Outstanding discussions! I especially like the fact they those are patient centered and touch upon some ethical/personal dilemmas! I really hope to hear annual update, thank you Dr. Love!
  • John.KH
    Hem/Onc fellow
    Because of this podcast my knowledge in this field has grown substantially. It has helped me to keep up with the new data to deliver the best care to my patients. Thank you Dr. Love
  • Bob a la sob mob
    The best
    Simply one of the best most complete and informative podcasts in any medical topic ever made. I am a pediatrician and do not treat cancer. Yet I listen to every new episode. Outstanding.
  • VeggieAsian
    Bad
    When will they realize that cancer or any major "disease" in developed country is just symptoms. Stop making expensive medication that only covers symptoms but admit that everyday diet and habit is the cause and fix it. There are many cancer survivors who didn't have any chemo or radiation or "medication" therapy but did radical diet change and life style change.
  • KirayFer
    Extraordinary
    Dr Neil love has always the ability to make the exact question to be answered, I just hope he comes out with more of this podcast. I listen to it while driving my motorcycle to work, keep the good work
  • Khazik
    Excellent
    Excellent podcast for surgeons and oncologists
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.